InMed Pharmaceuticals is a turnaround stock, with recent news updates showing promise for future gains
InMed Pharmaceuticals is a turnaround stock, with recent news updates showing promise for future gains
As it gets set to become the world's first legal recreational marijuana market, Canada is gearing up to be the main exporter for pot worldwide.
7,700 kg per annum facility to focus on high-margin concentrates, leveraging award-winning MPX brand.
Looking at how the expertise of InMed's management, consulting and advisory team combines to drive value for shareholders.
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc., is currently in the process of ramping-up its sales and marketing efforts within Los Angeles County for its newly-acquired PotSaver brand.
Specialized holding company SinglePoint, Inc. (OTC: SING) is the focus of a newly-released podcast interview announced this morning by Investorideas.com.
Grey Cloak Tech, Inc. (OTCQB: GRCK) today announced that its board of directors has decided to abandon and cancel the reverse stock split that was previously approved by both the board and the company’s shareholders in February 2017.
We think that InMed’s proprietary technology could put $6.6 Billion in play and make it one of the strongest biotech stocks in the market. We also think InMed is in the right place at the right time to create real value for investors in the Industry. Here's a few reasons why.
ChineseInvestors.com continues to rapidly grow in 2017, which is primarily attributed to the company’s focus on the CBD health products market.
Canopy Growth Corporation (TSX: WEED) is pleased to announce that it has launched a strategic partnership in the Jamaican cannabis market as part of its ongoing international expansion.
India Globalization Capital, Inc. (NYSE American: IGC) this morning announced that it has entered into a memorandum of understanding with MediCann Handels GmbH.
FinCanna Capital Corp. and Astar Minerals Ltd. (TSX.V: TAR) this morning announced that FinCanna will share 50 percent of the profits from Cultivation Technologies’ interim medical cannabis extraction facility operating in Coachella, California.
Funding was oversubscribed by 20%, led by Aphria and Green Acre Capital.
InMed announces results of a study co-sponsored with the University of British Columbia. The InMed-UBC study is the first ever to report hydrogel-mediated cannabinoid nanoparticle delivery to the eye, resulting in enhanced drug uptake via the cornea and lens. This study further validates the Company’s capacity to conduct a wide spectrum of drug development activities
Grey Cloak Tech, Inc. (OTCQB: GRCK) this morning announced that it has acquired Eqova Life Sciences, a medically-focused CBD company, in an all-stock transaction.